Gideon Goldstein

Last updated

Gideon Goldstein is an American medical doctor, biochemist and molecular biologist. [1] In 1975, while at the New York University School of Medicine, he led the research team that first reported the discovery of ubiquitin, a regulatory protein found in most tissues of eukaryotic organisms. [2] [3] He is currently at Thymon LLC, a pharmaceutical company he himself has founded. [4] [5]

References

  1. ↑ "Gideon Goldstein". ResearchGate. Retrieved 21 September 2025.
  2. ↑ Goldstein, G.; Scheid, M. P.; Hammerling, U.; Schlesinger, D. H.; Niall, H. D.; Boyse, E. A. (1975). "Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells". Proceedings of the National Academy of Sciences. 72 (1): 11–15. Bibcode:1975PNAS...72...11G. doi: 10.1073/pnas.72.1.11 . PMC   432229 . PMID   1078892.
  3. ↑ Wilkinson, Keith D. (2005-10-25). "The discovery of ubiquitin-dependent proteolysis". Proceedings of The National Academy of Sciences. 102 (43): 15280–15282. Bibcode:2005PNAS..10215280W. doi: 10.1073/pnas.0504842102 . PMC   1266097 . PMID   16230621.
  4. ↑ Goldstein, Gideon; Ensoli, Barbara; Fiorelli, Valeria; Zanetti, Matteo (April 2012). "Exploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naïve and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects". Human Vaccines & Immunotherapeutics. 8 (4): 479–485. doi:10.4161/hv.19184. PMID   22336878 . Retrieved 21 September 2025.
  5. ↑ Goldstein, Gideon (September 1996). "HIV-1 Tat protein as a potential AIDS vaccine". Nature Medicine. 2 (9): 960–964. doi:10.1038/nm0996-960. PMID   8782444 . Retrieved 21 September 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.